Mechanism of Action of 5-Nitrothiophenes against Mycobacterium tuberculosis
Author(s) -
Ruben C. Hartkoorn,
O. B. Ryabova,
Laurent R. Chiarelli,
Giovanna Riccardi,
Vadim Makarov,
Stewart T. Cole
Publication year - 2014
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.02693-13
Subject(s) - nitroreductase , mycobacterium tuberculosis , mechanism of action , streptomycin , mycobacterium , nitroimidazole , microbiology and biotechnology , chemistry , mutant , cofactor , tuberculosis , biology , bacteria , biochemistry , in vitro , antibiotics , enzyme , medicine , genetics , organic chemistry , pathology , gene
On using the streptomycin-starved 18b strain as a model for nonreplicatingMycobacterium tuberculosis , we identified a 5-nitrothiophene compound as highly active but not cytotoxic. Mutants resistant to 5-nitrothiophenes were found be cross-resistant to the nitroimidazole PA-824 and unable to produce the F420 cofactor. Furthermore, 5-nitrothiophenes were shown to be activated by the F420 -dependent nitroreductase Ddn and to release nitric oxide, a mechanism of action identical to that described for nitroimidazoles.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom